SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

OncoZenge reports 92% subscription rate in rights issue

OncoZenge AB's preliminary rights issue results indicate that approximately 92% of shares were subscribed for, with expected gross proceeds of SEK 30.7 million before costs. The subscription guarantee commitment from Vator Securities Ab is not expected to be utilized.

ONCOZ.ST

Related stories